Biosyent Stock Analysis
| RX Stock | CAD 11.25 0.05 0.45% |
Biosyent is fairly valued with Real Value of 11.24 and Hype Value of 11.24. The main objective of Biosyent stock analysis is to determine its intrinsic value, which is an estimate of what Biosyent is worth, separate from its market price. There are two main types of Biosyent's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Biosyent's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Biosyent's stock to identify patterns and trends that may indicate its future price movements.
The Biosyent stock is traded in Canada on TSX Venture Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Biosyent is usually not traded on Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day, Canada Day, Civic Holiday, Labour Day. Biosyent Stock trading window is adjusted to America/Toronto timezone.
Biosyent |
Biosyent Stock Analysis Notes
About 30.0% of the company outstanding shares are owned by corporate insiders. The book value of Biosyent was at this time reported as 3.22. The company last dividend was issued on the 28th of February 2025. BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells various pharmaceutical and other healthcare products in Canada and internationally. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006 to reflect its forward focus on the pharmaceutical market. BIOSYENT INC operates under Drug Manufacturers - Specialty Generic classification in Canada and is traded on TSX Venture Exchange. To find out more about Biosyent contact Ren Goehrum at 905 206 0013 or learn more at https://www.biosyent.com.Biosyent Investment Alerts
| Biosyent generated a negative expected return over the last 90 days | |
| About 30.0% of the company outstanding shares are owned by corporate insiders |
Biosyent Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 126.16 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biosyent's market, we take the total number of its shares issued and multiply it by Biosyent's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Biosyent Profitablity
Biosyent's profitability indicators refer to fundamental financial ratios that showcase Biosyent's ability to generate income relative to its revenue or operating costs. If, let's say, Biosyent is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Biosyent's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Biosyent's profitability requires more research than a typical breakdown of Biosyent's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.21 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.29 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.29. Technical Drivers
As of the 19th of March, Biosyent shows the Standard Deviation of 1.11, mean deviation of 0.7214, and Risk Adjusted Performance of (0.03). In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Biosyent, as well as the relationship between them. Please confirm Biosyent market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Biosyent is priced correctly, providing market reflects its regular price of 11.25 per share.Biosyent Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Biosyent middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Biosyent. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Biosyent Outstanding Bonds
Biosyent issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biosyent uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biosyent bonds can be classified according to their maturity, which is the date when Biosyent has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Biosyent Predictive Daily Indicators
Biosyent intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biosyent stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Biosyent Forecast Models
Biosyent's time-series forecasting models are one of many Biosyent's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biosyent's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Biosyent Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Biosyent prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biosyent shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Biosyent. By using and applying Biosyent Stock analysis, traders can create a robust methodology for identifying Biosyent entry and exit points for their positions.
BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells various pharmaceutical and other healthcare products in Canada and internationally. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006 to reflect its forward focus on the pharmaceutical market. BIOSYENT INC operates under Drug Manufacturers - Specialty Generic classification in Canada and is traded on TSX Venture Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Biosyent to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Additional Tools for Biosyent Stock Analysis
When running Biosyent's price analysis, check to measure Biosyent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosyent is operating at the current time. Most of Biosyent's value examination focuses on studying past and present price action to predict the probability of Biosyent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosyent's price. Additionally, you may evaluate how the addition of Biosyent to your portfolios can decrease your overall portfolio volatility.